SABS
SAB Biotherapeutics Inc · NASDAQ NMS - GLOBAL MARKET · Biotechnology
$3.76$-0.09 (-2.34%)
Prices delayed up to 5 minutes
AC Intelligence
AC Intelligence
AC Intelligence for SABS is being prepared.
Key Stats
Key Stats
Open
$3.82
Day High
$3.89
Day Low
$3.71
Prev Close
$3.85
Volume
0
Avg Volume
715.8K
Day Change
$-0.09
Change %
-2.34%
Fundamentals
Fundamentals
P/E
14.9
P/B
1.18
EPS (TTM)
$-1.42
Market Cap
$196M
52-Wk Range
$1.00 — $6.60
Earnings History
Insider Activity
Who Owns This Stock
Who Owns SABS
Other90.5%33 holders
Passive / Index5.5%3 holders
Tactical / Macro2.2%3 holders
Quality / Compounder0.8%1 holder
Systematic / Quant0.7%1 holder
Based on Q4 2025 13F filings + AC behavioral model
48 institutional holders
Top Holders
0.0%$42710.8B
$16461.6B
$16461.6B
$10662.3B
$8222.4B
$8222.2B
$8017.0B
+482.5%$6624.4B
$3004.0B
$2441.8B
$2170.4B
$1778.1B
$1212.1B
0.0%$1150.0B
$1060.8B
$778.8B
0.0%$748.0B
$548.1B
$422.1B
+608.6%$386.4B
Institutional Pressure
Market Regime:Strong Risk-Off (-0.62)SELLINGBUYING
▲
Mild Selling Pressure
Other(90.5%)
●
—Passive / Index(5.5%)
●
HoldsTactical / Macro(2.2%)
●
Reducing rapidlyQuality / Compounder(0.8%)
●
Holds throughSystematic / Quant(0.7%)
●
De-risking (mechanical)Dealer / Bank(0.3%)
●
Facilitating6% passive + quality floor won't sell.
Updated daily · Based on Q4 2025 filings + AC behavioral model
Sentiment Signals
Sentiment Signals
→Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Analyst Consensus13 buy, 1 hold, 0 sellFinnhub
↑↑Inst. Flows45 increased/new, 6 decreased/exited (13F)AC 13F Analysis
Sources: SEC Form 4, Finnhub, AC 13F Analysis
On AcidCapitalist
On AcidCapitalist
No recent mentions of SABS on AcidCapitalist.
Data provided by Finnhub. Prices delayed up to 5 minutes.